The Best Platforms to Sell Pre-IPO Shares in 2026

Photo by Kindel Media

Private secondary markets were created out of the fact that early investors, employees and fund managers didn’t have years to wait to get the cash value in paper shares through an IPO. Selling shares of an unlisted company in the secondary market involves a venue that connects buyers and sellers, handles the company’s right of first refusal and sorts the securities-related paperwork.

 

U.S. venture secondary volume hit an estimated $61.1 billion in the twelve months ending June 2025, more than all VC-backed IPOs combined over the same time period. Here is how these five platforms are used to sell pre-IPO shares.

1. MicroVentures

Pre-IPO/private secondary markets: MicroVentures operated under Regulation D secondaries to allow the sale of secondary stakes by existing shareholders in last-stage companies, while using Regulation Crowdfunding for primary offerings, targeting accredited buyers.

 

Accredited investor requirements: These fall under the standard SEC test; $1 million in assets excluding your home, or a $200k salary (or $300k jointly). All regulation D secondaries are called to confirm accreditation before providing access to the private secondary sales.

 

Employee stock options / RSUs and tender offers: Mostly transacted via standard listed secondary trades rather than directly through a tender offer initiated by an issuer. RSUs pass through a secondary listing mechanism to the platform.

 

Share valuation methods: Pricing is anchored to the companies’ last funding round and then further analyzed by its diligence team; there is no order book for shares.

 

Liquidity events: Previously opened secondary access to pre-IPO companies like Slack and Airbnb through its platform.

 

Fees and transaction structure: Regulation D transactions incur a 5% placement fee plus 1.5% of costs at settlement, while Regulation Crowdfunding shares are free to list.

 

Regulatory/compliance consideration: Is FINRA- and SIPC-registered, subject to SEC Rule 144 regarding holding periods.

 

Kraken specific details: Kraken shares are not available to buy/sell on the platform.

 

Pros:

• Grants access at very low minimums.
• More than 60,000 accredited investors.

 

Cons:

• Deal flow is not as frequently refreshed as platforms that are specifically created for live trading.

 

Use Cases: Ideal for the buy-and-hold investor looking for an account that spans early-stage and mature equity, versus fund managers hunting a specific deal.

 

2. Hiive

Pre-IPO/private secondary markets: Hiive lists more than 3,000 pre-IPO companies that have live and visible order books, so buyers and sellers are able to see actual bids and asks.

 

Accredited investor requirements: Standard U.S. accredited investor qualifications, or the United Kingdom’s equivalent being the FCA’s high net worth and self-certified investor categories are required for access.

 

Employee stock options / RSUs and tender offers: Employees are able to sell listed shares (after vesting) either directly via the order book, or through SPV facilitated by Sydecar on Hiive Funds.

 

Share valuation methods: Actual matched sales prices determine listed prices; the Hiive 50 Index traces 50 liquid names and is driven by real user orders and not appraisers.

 

Liquidity events: Coverage includes SpaceX, Stripe, Anthropic, OpenAI, and more, in which cases Hiive may function as an intermediary in place of an IPO, sale, or tender offer.

 

Fees and transaction structure: Hiive’s June 2026 Form CRS shows maximum rates of 4.85% for buyers and a maximum rate of 5.75% for sellers on direct trades, decreasing on higher volumes. Typical fee ranges between 2.5% to 5% depending on transaction volume and structure. Many of Hiive securities products do not carry annual management fees.

 

Regulatory/compliance consideration: Hiive is FINRA / SIPC-regulated and an Exempt Market dealer across several provinces in Canada. Right of first refusal outcomes are disclosed at 18% during 2024, plus an additional 10% of transactions either being abandoned or not approved from direct trades.

 

Kraken specific details: Hiive facilitates secondary share trading for Kraken, serving as one of the platform’s more liquid fintech offerings. For accredited buyers tracking potential IPO runways, accessing these direct live bid/ask spreads provides investment insights for Kraken before a public listing.

 

Pros:

• Provides sellers with detailed information rather than a single quote.
• Broader choice than what is found on pure marketplaces.

 

Cons:

• Direct sales fees are high.
• High rate of abandoned or unapproved direct trades.

 

Use Cases: Seller or buyers who seek market-driven discovery, or buy-and-hold investors in securities that take advantage of a no-carry structure investment fund. Hiive has a 4.5 star review on Trustpilot from various clients.

3. Linqto

Pre-IPO/private secondary markets: Historically funneled retail cash into Special Purpose Vehicles which owned stock in Ripple, Circle and SpaceX, thus giving a backdoor to smaller investors.

 

Accredited investor requirements: It services accredited investors, however, in bankruptcy filings it was revealed that that stock it had sold had also been pushed to non-accredited investors.

 

Employee stock options / RSUs and tender offers: As Linqto operated pooled vehicles and did not facilitate direct transfers of share certificates, customers were never entitled to ownership of the company stock itself, a loophole central to the alleged fraud claim.

 

Share valuation methods: The SEC charges explain the firm marked up the value of Ripple shares it acquired for approximately 60%, over and above its cost. This far exceeds the SEC’s 10% standard.

 

Liquidity events: Ripple exposure alone was estimated to be between $450 million and $800 million with more than $500 million invested across a total of 111 companies.

 

Fees and transaction structure: No longer relevant, the operation was shut down in March 2025, shortly before it entered Chapter 11 bankruptcy proceedings that July.

 

Regulatory/compliance consideration: Both the SEC and DOJ have opened investigations; FINRA reviewed its broker-dealer in late 2024.

 

Kraken specific details: No active marketplace to buy Kraken or any other pre-IPO name.

 

Pros:

• Had access to harder-to-obtain names, like Ripple, to an average consumer.

 

Cons:

• Chapter 11 bankruptcy filings during July 2025.

 

Use Cases: None, the bankruptcy proceedings, now at the liquidating trust stage having gained court approval in February 2026, and can be used as a future point of reference for evaluating the disclosure process for similar firms.

 

4. CartaX

Pre-IPO/private secondary markets: Carta launched an auction-based exchange in 2021 that facilitated its first transaction by conducting the sale of Carta’s shares worth $99.7 million for more than 400 stakeholders before making it accessible to the public.

 

Accredited investor requirements: Transactions were restricted to only verified accredited investors who underwent the same stringent access measures as to how Carta offers products to cape table investors.

 

Employee stock options / RSUs and tender offers: Unlike readily available peer to peer stock lists, the system concentrated its operations on tenders and auctions that were initiated by issuers for equity currently documented on the Carta platform.

 

Share valuation methods: Instead of day-to-day trading, periodic company auctions determined prices for the stocks thus presenting discrete valuations that were fixed instead of ongoing market appraisals.

 

Liquidity events: Carta’s own 2021 employee tender netted a 2.5x premium over its prior funding round through CartaX’s price discovery.

 

Fees and transaction structure: Carta has not published any publicly available fees since narrowing its product range in 2024.

 

Regulatory/compliance consideration: CartaX now exists narrowly as tender-offer infrastructure for issuers already on Carta, not a marketplace outside buyers can browse.

 

Kraken specific details: Given its narrowed, buyer-limited nature, offering Kraken would not be accessible or feasible.

 

Pros:

• Had organic access to companies already using Carta for equity management.

 

Cons:

• Limited access for outside buyers.

 

Use Cases: Applicable to firms already running equity through Carta, seeking a non-external buy-on via an internal tender offer rather than toward single financiers seeking opportunities in pre-public firms.

5. Augment

Pre-IPO/private secondary markets: Augments runs ‘The Pulse’ a dashboard tracking pricing across more than 300 private companies, and also offers a live market to trade directly.

 

Accredited investor requirements: Trades are limited to accredited investors via the standard federal definition as contained in the standard SEC test.

 

Employee stock options / RSUs and tender offers: Vested shareholders are able to list shares directly, or can access under the Augment ‘Collective’ pooled structure, allowing for fractional ownership.

 

Share valuation methods: Publishes real-time prices for a wider range of companies on their platform, although the site also acknowledges that pricing is only indicative with pricing only available to verified users.

 

Liquidity events: Listings available include those related to SpaceX, Anthropic, Stripe, and Databricks, weighing heavily toward AI and late-stage technology companies.

 

Fees and transaction structure: A $10,000 minimum structure required, among the lowest direct-purchase thresholds. Detailed commission pricing has not been published.

 

Regulatory/compliance consideration: Augment functions both as a FINRA registered broker-dealer and an SEC-supervised ATS under Rule 144.

 

Kraken specific details: Published company lists lean toward AI and enterprise software names, however does not specifically list Kraken shares.

 

Pros:

• Low minimum purchase price of $10,000.
• Raised $100.3 million for infrastructure.

 

Cons:

• No deep trading history available.
• Inexperienced as private market access has not run a full cycle.

 

Use Cases: The best fit for investors beginning their entry into the world of pre-IPO share purchases due to a low investment minimum, rather than professional fund managers trading blocks of shares.

 

Quick Comparison Table

Platform	Typical Fees	Key Feature	Best For	Limitation
MicroVentures	5% Placement + 1.5% offering cost	Runs both primary and secondary offerings	Investors who also want early-stage crowdfunding	$10,000 secondary minimum
Hiive	Up to 4.85% buyer / 5.75% seller	Live order book, hourly Hiive50 Index	Sellers who want real bid/ask activity	Higher percentage of transfers that don’t close
Linqto	N/A, inactive	Formerly SPV access to Ripple	No one, as the company filed for bankruptcy	Chapter 11 bankruptcy filling
CartaX	N/A as an open marketplace	Tender-offer tool tied to Carta cap tables	Companies already on Carta	Open marketplace closed
Augment	Real-time pricing, $10k minimum	‘The Pulse’ dashboard	Newer investors wanting low entry cost	Thin track record and trading depth

 

Frequently Asked Questions

What is the best platform to sell pre-IPO shares right now?

Hiive is a great all-around choice due to the highest company coverage and best live price access. MicroVentures is better if you’re also interested in crowdfunding opportunities, or Augment for smaller first-time trades. The best platform will depend on what matters to you most.

 

Where can I sell the equity of my startup before it goes public?

Pre-IPO investment occurs on private secondary markets. It usually requires the parties involved to have accredited-investor status or to use a pooled-vehicle like with secondary platforms.

 

What is the cheapest pre-IPO secondary market?

Hiive carries a zero management and carry fee while those at MicroVentures charge a 5% fee on Regulation D deals. Always ask current rates directly to the platform when buying or selling.

Conclusion

The Problem: Private secondary markets provide essential pro-IPO liquidity, but inconsistent pricing models,variable fee schedules, and regulatory risks makes selecting the right platform difficult.

 

Key takeaways: Hiive excels in live order-book transparency, MicroVentures and Augment offer low entry points, CartaX focuses on issuer-led internal tenders and Linqto highlights the necessity of platform risk diligence.

 

Next Steps:

1. Verify your accredited investor status.
2. Compare each platform’s specific fee structures, minimums, and transfer approval rates.
3. Confirm active listing depth and price discovery for your target pre-IPO shares.